A Reminder App to Improve Physical Activity During Radiotherapy for Lung Cancer - a Pre-study in Healthy Volunteers
APART-LUNG
1 other identifier
interventional
30
2 countries
2
Brief Summary
Physical activity prior to and during chemo- and/or immunotherapy for lung cancer appears important. This may also be true for patients with lung cancer treated with radiation therapy. However, adherence to an exercise program sometimes may be challenging for the patients, particularly if they experience fatigue or other adverse events. The question arose whether an easy-to-use mobile app installed on the patient's smart phone reminding patients several times daily to perform a certain number of steps will have a positive effect on their physical activity during a course of radiation therapy. Such an app has been developed within the Interreg project HeAT (Health Advancing Technologies for Elderly). However, before this app can be tested in a prospective trial involving patients, its usability should to be evaluated by healthy volunteers. In the present prospective study, 30 healthy volunteers test and rate ten aspects related to the usability of the app. The healthy volunteers have to download a reminder app, which has been designed by the Lübeck based company Nextlabel Offene Handelsgesellschaft (OHG). After receiving the link for the download of the app from Nextlabel OHG by e-mail, the participants are asked to test the app and complete a questionnaire. They are asked to affirm or negate ten statements in three sections (download and installation, navigation, and content/functions) regarding the usability of the reminder app. The satisfaction rate represents the rate of participants who affirmed a statement. If this rate was \<60%, the reminder app was rated as not being useful. If the rate was between ≥60% but \<80%, the app was regarded useful but required further optimization regarding the corresponding section. In addition, iPhone and Android users are compared with respect to the satisfaction rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable lung-cancer
Started Mar 2026
Shorter than P25 for not_applicable lung-cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2026
CompletedFirst Submitted
Initial submission to the registry
May 5, 2026
CompletedFirst Posted
Study publicly available on registry
May 15, 2026
CompletedMay 15, 2026
May 1, 2026
1 month
May 5, 2026
May 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Satisfaction with the reminder app
The participants are asked to affirm or negate ten statements in three sections (download and installation, navigation, and content/functions) regarding the usability of the reminder app. The satisfaction rate represents the rate of participants who affirmed a statement. If this rate was \<60%, the reminder app was rated as not being useful. If the rate was between ≥60% but \<80%, the app was regarded useful but required further optimization regarding the corresponding section.
Day 1
Study Arms (1)
Healthy volunteers evaluating a reminder app
OTHERParticipants are asked to test the app and complete a questionnaire. They are asked to affirm or negate ten statements in three sections (download and installation, navigation, and content/functions) regarding the usability of the reminder app.
Interventions
The participants evaluate a mobile app installed on their smart phone reminding them several times daily to perform a certain number of steps. the participants are asked to complete a questionnaire and to affirm or negate ten statements in three sections (download and installation, navigation, and content/functions) regarding the usability of the app.
Eligibility Criteria
You may qualify if:
- Possession of and ability to use a smart phone plus a step counter
- Age ≥18 years
- Written informed consent
- Capacity of the participant to consent
You may not qualify if:
- \. Expected non-compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Oncology Vejle Hospital, University Hospital of Southern Denmark
Vejle, 7100, Denmark
Department of Radiation Oncology, University of Luebeck
Lübeck, Schleswig-Holstein, 23562, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dirk Rades, Prof. Dr. med., FASTRO
University of Luebeck, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2026
First Posted
May 15, 2026
Study Start
March 19, 2026
Primary Completion
April 21, 2026
Study Completion
April 21, 2026
Last Updated
May 15, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share